Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 83.58%1.68B | -26.59%912.91M | -21.66%1.24B | 19.48%1.59B | 37.20%1.33B | -11.05%968.39M | 92.54%1.09B | 565.47M |
| Cost of revenue | 83.38%1.65B | -27.04%901.35M | -21.72%1.24B | 20.08%1.58B | 37.21%1.31B | -11.06%957.91M | 94.35%1.08B | 554.13M |
| Gross profit | 99.54%23.07M | 41.45%11.56M | -11.84%8.17M | -35.14%9.27M | 36.33%14.29M | -10.83%10.48M | 3.70%11.76M | 11.34M |
| Operating expense | 239.22%40.12M | 47.66%11.83M | -6.64%8.01M | -3.84%8.58M | 13.47%8.92M | 101.97%7.86M | 13.14%3.89M | 3.44M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | ---- | 16.07%2.53M | --2.18M |
| Selling and administrative expenses | 239.22%40.12M | 47.66%11.83M | -6.64%8.01M | -3.84%8.58M | 13.47%8.92M | 409.58%7.86M | 91.92%1.54M | --804K |
| -General and administrative expense | 239.22%40.12M | 47.66%11.83M | -6.64%8.01M | -3.84%8.58M | 13.47%8.92M | 409.58%7.86M | 91.92%1.54M | --804K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | 60.45%430K | --268K |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | 60.45%430K | --268K |
| Rent and land expenses | ---- | ---- | ---- | ---- | ---- | ---- | -18.45%84K | --103K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | -11.96%184K | --209K |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | 623.97%876K | --121K |
| Operating profit | -6,260.91%-17.06M | -265.06%-268.14K | -76.45%162.45K | -87.16%689.82K | 104.87%5.37M | -66.67%2.62M | -0.41%7.86M | 7.9M |
| Net non-operating interest income (expenses) | 207.04%111.26K | 73.01%-103.94K | 26.21%-385.17K | -292.73%-522.01K | -3,773.74%-132.92K | 102.68%3.62K | -509.09%-135K | 33K |
| Non-operating interest income | 162.97%391.23K | 75.61%148.77K | 21.04%84.71K | -13.23%69.99K | 14.15%80.66K | 7.07%70.66K | 3.13%66K | --64K |
| Non-operating interest expense | 10.78%279.96K | -46.22%252.71K | -20.63%469.88K | 177.18%592K | 218.56%213.58K | -59.85%67.05K | 1,418.18%167K | --11K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | 70.00%34K | --20K |
| Net investment income | -48.33%1.22M | 335.84%2.37M | 331.05%543.1K | 47.53%125.99K | 33.67%85.4K | 103.95%63.89K | 18.34%-1.62M | -1.98M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||
| Income from associates and other participating interests | ||||||||
| Special income (charges) | -29.94%23.82K | 34K | 0 | |||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | 29.94%-23.82K | ---34K | ---- |
| Other non-operating income (expenses) | 64.53%62.43K | -17.31%37.94K | -90.99%45.89K | 599.56%509.08K | -42.87%72.77K | 183.08%127.39K | -55.88%45K | 102K |
| Income before tax | -870.30%-15.66M | 455.03%2.03M | -54.38%366.27K | -85.12%802.89K | 89.99%5.4M | -54.13%2.84M | 2.31%6.19M | 6.05M |
| Income tax | -136.74%-184.22K | 103.87%501.43K | -62.23%245.96K | -51.49%651.28K | 28.65%1.34M | -27.43%1.04M | -17.88%1.44M | 1.75M |
| Net income | -1,110.49%-15.48M | 1,172.99%1.53M | -20.65%120.3K | -96.26%151.61K | 125.62%4.05M | -62.21%1.8M | 10.53%4.75M | 4.3M |
| Net income continuous operations | -1,110.49%-15.48M | 1,172.99%1.53M | -20.65%120.3K | -96.26%151.61K | 125.62%4.05M | -62.21%1.8M | 10.53%4.75M | --4.3M |
| Noncontrolling interests | 1,490.81%208.62K | 2.78%-15K | -1,262.99%-15.43K | -1.13K | 0 | |||
| Net income attributable to the company | -1,114.18%-15.68M | 1,039.34%1.55M | -11.14%135.73K | -96.23%152.74K | 125.62%4.05M | -62.21%1.8M | 10.53%4.75M | 4.3M |
| Preferred stock dividends | ||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -1,114.18%-15.68M | 1,039.34%1.55M | -11.14%135.73K | -96.23%152.74K | 125.62%4.05M | -62.21%1.8M | 10.53%4.75M | 4.3M |
| Gross dividend payment | ||||||||
| Basic earnings per share | -1,105.77%-0.0523 | 940.00%0.0052 | 0.00%0.0005 | -96.30%0.0005 | 125.45%0.0135 | -62.21%0.006 | 10.53%0.0158 | 0.0143 |
| Diluted earnings per share | -1,105.77%-0.0523 | 940.00%0.0052 | 0.00%0.0005 | -96.30%0.0005 | 125.45%0.0135 | -62.21%0.006 | 10.53%0.0158 | 0.0143 |
| Dividend per share | 0 | 0 | 0 | 0.0099 | ||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.